. 2018 Jan 8;50(4):1324–1330. doi: 10.4143/crt.2017.526
Copyright © 2018 by the Korean Cancer Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 3.
Progression-free survival according to the primary tumor site.